Program Highlights
Fireside Chat with Cheryl Scott, Chief Operating Officer of the Bill & Melinda Gates Foundation
High-level roundtables:- A global assault on malaria: What will it take to contain the disease?
- An industry call to action with leaders in biotech
- Addressing global health from bench to bedside with global health luminaries
- Presentations by 15 organizations funding and supporting global health product development including the leading product development partnerships (PDPs), the Bill & Melinda Gates Foundation and the International Finance Corporation
- Nearly 30 company presentations given by leading innovators involved in the discovery and development of global health products including vaccines, drugs and diagnostics. Innovators include GlaxoSmithKline, Seattle Biomedical Research Institute, Sabin Vaccine, ChemBio, Micronics, Dafra Pharma, Sentinex, U.S. Department of Defense
- Registered attendees will have opportunities to meet individually with companies, funders and NGOs to discuss possible collaborations and partnerships
- The latest trends in R&D
- Lessons learned from partnering and innovative new business models
- Markets and incentives
Track 1: R&D / Disease Linkages |
| How Can Biotech Bridge the Global Health Innovation Gap? Needs and Opportunities in Diagnostics: Creating sustainable solutions for the developing world Building the R&D Capabilities within Developing Countries |
Track 2: Partnering / Business Models |
| Co-Development/Partnerships with Emerging Market Manufacturers: Advantages, opportunities and models Ensuring Access: New approaches to IP New Models of Collaboration Partnership Lessons and Stories from the Trenches |
Track 3: Markets / Incentives |
| New Market Incentive to Pull Industry Investment: How much are priority review vouchers really worth to global health? Bridging Innovation and Access: Policy's contribution to global health Uncovering Viable Markets for Global Health: How much is enough? |